Press release
Parkinson’s Disease Treatment Market Size, Share, Analysis and Forecast - 2025
Global Parkinson’s Disease Treatment Market Size, Share & Trends Analysis Report by Type ((Drugs (Dopamine Receptor Agonists, MAO-Inhibitors, Carbidopa-Levodopa, Catechol O-methyltransferase (COMT) Inhibitors, Anticholinergics, and Others) and Surgical Procedures (Deep Brain Stimulation, Vagus Nerve Stimulation, and Others), Fo The global Parkinson’s disease treatment market is expected to grow at a CAGR of over 6% during the forecast period. The primary factors that drive the growth of the global Parkinson’s disease treatment industry include the increased incidences of Parkinson’s diseases across the globe. The increased prevalence of neurological disorders such as Parkinson’s and other diseases have encouraged the players to perform R&D activities for the development of novel and advanced treatment options. Also, various studies have been done to develop the total cure and increased effectiveness of the treatment of the disease.Get Sample Copy of Parkinson’s Disease Treatment Market at: https://www.omrglobal.com/request-sample/parkinsons-disease-treatment-market
Some of the prominent players functioning in the global Parkinson’s disease treatment market Medtronic Plc, AbbVie Inc., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Boston Scientific Corp., Cipla Inc., Mylan NV, Novartis International AG, Eli Lilly& Co., Pfizer Inc., and Teva Pharmaceutical Industries Ltd. among others.
In August 2019, a study was conducted by Johns Hopkins Medicine associated with Parkinson’s disease via deep brain stimulator (DBS) treatment. The DBS through electrical impulses jump starts the nerve cells that produce the dopamine to lessens muscle rigidity and tremors that are the basic symptoms of Parkinson’s disease. The research was performed on seven people to study the change in dopamine levels in the brain.
The researchers performed PET (Positron Emission Tomography) scan on a patient with Parkinson’s disease taking dopamine increasing medications (levodopa), using a tracer for Vesicular Monoamine Transporter 2 (VMAT2). The scans showed that, as the dopamine levels in the brain increase with levodopa, VMAT2 levels decrease, and vice versa. The researchers found that, after DBS, patients having Parkinson’s disease had fewer tremors and less rigidity, and patients showed improvement in cognitive abilities and mood, with depression scores dropping by 40%.
For More Information, get A full report of Parkinson’s Disease Treatment Market is available at: https://www.omrglobal.com/industry-reports/parkinsons-disease-treatment-market
Further, the global Parkinson’s disease treatment market has significant players operating in the industry and providing medications and surgical procedures globally. These players are significantly contributing to expanding the global Parkinson’s disease treatment market size during the forecast period.
Current Market Trends Covered in the market report:
Increased spending on the healthcare R&D activities by the government and private organizations are positively affecting the Parkinson’s disease treatment market growth
Deep Brain Stimulators (DBS) segment will account for significant growth in the market
The novel innovations and product enhancements will be the key strategy adopted by the players
The Asia-Pacific region will register a significant growth rate in Parkinson’s Disease Treatment market globally
Global Parkinson’s Disease Treatment Market – Segmentation
By Type
• Drugs
• Surgical Procedures
Global Parkinson’s Disease Treatment Market – Segmentation by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
•
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/parkinsons-disease-treatment-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
For More Information, Visit https://www.omrglobal.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parkinson’s Disease Treatment Market Size, Share, Analysis and Forecast - 2025 here
News-ID: 2094848 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Parkinson’s
Parkinson’s Disease Treatment Market 2021 | Detailed Report
Parkinson’s Disease Treatment Market Forecasts report provided to identify significant trends, drivers, influence factors in global and regions, agreements, new product launches and acquisitions, Analysis, market drivers, opportunities and challenges, risks in the market, cost and forecasts to 2027.
Get Free Sample PDF (including full TOC, Tables and Figures) of Parkinsons Disease Treatment Market @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5024082
The report provides a comprehensive analysis of company profiles listed below:
- Teva
- Roche
- Prothena
- Acorda…
Parkinson’s Disease Treatment Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Parkinson’s Disease Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Parkinson’s Disease Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Parkinson’s Disease Treatment with respect…
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds…
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that…
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports.
Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,…
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent.
Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial…